Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Weiss

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trialsChristian Weiss, Dirk Arnold, Kathrin Dellas, et al.
Anticancer Research|April 19, 2011
15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatmentFrens Steffen Krause, Bernhard Walter, Oliver Josef Ott, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 14, 2005
Combined-modality treatment and organ preservation in bladder cancer. Do molecular markers predict outcome?Christian Weiss, Franz Rödel, Ina Wolf, et al.
Clinical Drug Investigation|August 1, 2008
Rationale for and design of the CREATIVE-AF trial: randomized, double-blind, placebo-controlled, crossover study of the effect of irbesartan on oxidative stress and adhesion molecules in patients with persistent atrial fibrillationAndreas Goette, Alessandra D'Alessandro, Alicja Bukowska, et al.
Cardiology|July 14, 2007
Stable and unstable ventricular tachycardias in patients with previous myocardial infarction: a clinically oriented strategy for catheter ablationRodolfo Ventura, Hanno U Klemm, Thomas Rostock, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2002
High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resectionFranz Rödel, Jörg Hoffmann, Gerhard G Grabenbauer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2007
Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapyChristian Weiss, Michael Wittlinger, Dirk G Engehausen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 20, 2009
Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermiaMichael Wittlinger, Claus M Rödel, Christian Weiss, et al.
BMC Cardiovascular Disorders|June 30, 2018
INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact)Claudius Hansen, Christian Loges, Karlheinz Seidl, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapyChristian Weiss, Felix von Römer, Gianni Capalbo, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trialsChristian Weiss, Dirk Arnold, Kathrin Dellas, et al.
Anticancer Research|April 19, 2011
15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatmentFrens Steffen Krause, Bernhard Walter, Oliver Josef Ott, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 14, 2005
Combined-modality treatment and organ preservation in bladder cancer. Do molecular markers predict outcome?Christian Weiss, Franz Rödel, Ina Wolf, et al.
Clinical Drug Investigation|August 1, 2008
Rationale for and design of the CREATIVE-AF trial: randomized, double-blind, placebo-controlled, crossover study of the effect of irbesartan on oxidative stress and adhesion molecules in patients with persistent atrial fibrillationAndreas Goette, Alessandra D'Alessandro, Alicja Bukowska, et al.
Cardiology|July 14, 2007
Stable and unstable ventricular tachycardias in patients with previous myocardial infarction: a clinically oriented strategy for catheter ablationRodolfo Ventura, Hanno U Klemm, Thomas Rostock, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2002
High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resectionFranz Rödel, Jörg Hoffmann, Gerhard G Grabenbauer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2007
Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapyChristian Weiss, Michael Wittlinger, Dirk G Engehausen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 20, 2009
Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermiaMichael Wittlinger, Claus M Rödel, Christian Weiss, et al.
BMC Cardiovascular Disorders|June 30, 2018
INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact)Claudius Hansen, Christian Loges, Karlheinz Seidl, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapyChristian Weiss, Felix von Römer, Gianni Capalbo, et al.
Pageof 9